ATE250421T1 - Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung - Google Patents
Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendungInfo
- Publication number
- ATE250421T1 ATE250421T1 AT00960126T AT00960126T ATE250421T1 AT E250421 T1 ATE250421 T1 AT E250421T1 AT 00960126 T AT00960126 T AT 00960126T AT 00960126 T AT00960126 T AT 00960126T AT E250421 T1 ATE250421 T1 AT E250421T1
- Authority
- AT
- Austria
- Prior art keywords
- methylsulfonylmethane
- glucosamine
- extract
- composition containing
- perna canaliculus
- Prior art date
Links
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 title abstract 2
- 241001537211 Perna canaliculus Species 0.000 title abstract 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002442 glucosamine Drugs 0.000 title abstract 2
- 229940016409 methylsulfonylmethane Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 title abstract 2
- 210000002808 connective tissue Anatomy 0.000 abstract 1
- 210000005067 joint tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14239299P | 1999-07-06 | 1999-07-06 | |
| PCT/US2000/040298 WO2001001976A2 (en) | 1999-07-06 | 2000-07-06 | Composition comprising an extract of perna canaliculus, methylsulfonylmethane and glucosamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE250421T1 true ATE250421T1 (de) | 2003-10-15 |
Family
ID=22499671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00960126T ATE250421T1 (de) | 1999-07-06 | 2000-07-06 | Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1227826B1 (de) |
| AT (1) | ATE250421T1 (de) |
| AU (1) | AU771808B2 (de) |
| CA (1) | CA2375743C (de) |
| DE (1) | DE60005548T2 (de) |
| DK (1) | DK1227826T3 (de) |
| ES (1) | ES2207550T3 (de) |
| MX (1) | MXPA02000052A (de) |
| PT (1) | PT1227826E (de) |
| WO (1) | WO2001001976A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070141181A1 (en) | 1998-02-13 | 2007-06-21 | Nutramax Laboratories, Inc. | Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| WO2002028400A1 (en) * | 2000-10-03 | 2002-04-11 | Nutraceutics Limited | A therapeutic formulation containing glucosamine, methylsulfonymethane and eventually ascorbic acid and manganese |
| ITBS20040068A1 (it) * | 2004-05-24 | 2004-08-24 | Gen Topics Srl | Composizione cosmetica e/o farmaceutica per il trattamento della rosacea |
| NZ574317A (en) * | 2009-01-20 | 2010-10-29 | Bomac Research Ltd | Improved animal treatment |
| NZ575985A (en) * | 2009-03-31 | 2010-04-30 | Bomac Research Ltd | Medicament Uptake |
| AU2021221725A1 (en) * | 2021-08-25 | 2023-03-16 | Beyond Capital LP | Improvements in and relating to compositions for alleviating the effects/symptoms of inflammation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ314867A (en) * | 1997-05-21 | 1999-04-29 | Mcfarlane Lab New Zealand Ltd | Glucosamine and mussel extract compositions for use as anti-inflammatories |
| ZA995557B (en) * | 1998-05-29 | 2000-04-12 | Log Negentien Beleggings Pty L | A chemical substance. |
| DE19838794A1 (de) * | 1998-08-26 | 2000-03-09 | Aristavet Veterinaerspezialita | Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels |
| US6417227B1 (en) * | 1999-04-28 | 2002-07-09 | Cg And Associates | Methods of delivery of cetyl myristoleate |
-
2000
- 2000-07-06 ES ES00960126T patent/ES2207550T3/es not_active Expired - Lifetime
- 2000-07-06 AT AT00960126T patent/ATE250421T1/de not_active IP Right Cessation
- 2000-07-06 DK DK00960126T patent/DK1227826T3/da active
- 2000-07-06 CA CA002375743A patent/CA2375743C/en not_active Expired - Fee Related
- 2000-07-06 AU AU71333/00A patent/AU771808B2/en not_active Ceased
- 2000-07-06 PT PT00960126T patent/PT1227826E/pt unknown
- 2000-07-06 EP EP00960126A patent/EP1227826B1/de not_active Expired - Lifetime
- 2000-07-06 DE DE60005548T patent/DE60005548T2/de not_active Expired - Fee Related
- 2000-07-06 WO PCT/US2000/040298 patent/WO2001001976A2/en not_active Ceased
- 2000-07-06 MX MXPA02000052A patent/MXPA02000052A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001001976A2 (en) | 2001-01-11 |
| CA2375743C (en) | 2008-11-18 |
| DK1227826T3 (da) | 2004-01-12 |
| DE60005548T2 (de) | 2004-08-05 |
| EP1227826A2 (de) | 2002-08-07 |
| WO2001001976A3 (en) | 2002-05-10 |
| PT1227826E (pt) | 2004-02-27 |
| MXPA02000052A (es) | 2003-07-21 |
| EP1227826B1 (de) | 2003-09-24 |
| CA2375743A1 (en) | 2001-01-11 |
| AU7133300A (en) | 2001-01-22 |
| AU771808B2 (en) | 2004-04-01 |
| DE60005548D1 (de) | 2003-10-30 |
| ES2207550T3 (es) | 2004-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
| EA200100872A1 (ru) | Композиция валдекоксиба | |
| CY1116464T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
| CY1111433T1 (el) | Φαρμακευτικο τυποποιημενο παρασκευασμα δεσιταβινης | |
| TW200612987A (en) | Combination treatment for non-hematologic malignancies | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
| BR0108173A (pt) | Composições farmacêuticas de toxina de botulina | |
| NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
| DE69710065D1 (de) | Androsten-derivate | |
| BR0012175A (pt) | Antagonistas de receptor de igiur5, seletivos para o tratamento de enxaqueca | |
| ATE332136T1 (de) | Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten | |
| BR0209922A (pt) | Método para tratar uma condição médica que envolve a angiogênese em um paciente, para inibir a vascularização de células endoteliais, e para tratar câncer em um mamìfero | |
| DE60040753D1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
| UA90668C2 (ru) | Состав для лечения хронической венозной недостаточности, который содержит водный экстракт листьев красного винограда и противовоспалительное средство | |
| EP1178796A4 (de) | Aminoimidazolcarboxamidesalze zur vorbeugung und behandlung von leberkrankheiten | |
| ATE250421T1 (de) | Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung | |
| PA8525801A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
| ATE415965T1 (de) | Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung | |
| DE60236299D1 (de) | Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe | |
| DE60309926D1 (de) | Steroid-verbindungen mit anti-tumoraler wirkung | |
| ATE271867T1 (de) | Behandlung der harninkontinenz und zusammenstellung dafür | |
| MXPA05003633A (es) | 2"-oxo-voruscharina y derivados de la misma. | |
| BRPI0414454A (pt) | agentes antibacterianos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1227826 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |